1. Home
  2. ARQT vs ENVA Comparison

ARQT vs ENVA Comparison

Compare ARQT & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$22.18

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$135.55

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
ENVA
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ARQT
ENVA
Price
$22.18
$135.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$34.00
$173.00
AVG Volume (30 Days)
1.2M
212.4K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
88.79
55.05
EPS
N/A
11.52
Revenue
$376,072,000.00
$3,151,653,000.00
Revenue This Year
$34.46
$149.91
Revenue Next Year
$29.77
$15.38
P/E Ratio
N/A
$11.90
Revenue Growth
91.34
18.58
52 Week Low
$11.86
$79.41
52 Week High
$31.77
$176.68

Technical Indicators

Market Signals
Indicator
ARQT
ENVA
Relative Strength Index (RSI) 37.45 38.34
Support Level $22.56 $113.52
Resistance Level $27.26 $149.49
Average True Range (ATR) 0.92 4.58
MACD -0.13 0.15
Stochastic Oscillator 22.56 10.24

Price Performance

Historical Comparison
ARQT
ENVA

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: